Stay updated on Seladelpar in PBC Subjects Clinical Trial
Sign up to get notified when there's something new on the Seladelpar in PBC Subjects Clinical Trial page.

Latest updates to the Seladelpar in PBC Subjects Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check18 days agoChange DetectedAdded the full ASSURE study details for Seladelpar in Primary Biliary Cholangitis (PBC), including expanded US and international locations, updated inclusion/exclusion criteria, design, and outcome measures. The page now reflects current protocol information and replaces older content.SummaryDifference2%

- Check25 days agoNo Change Detected
- Check47 days agoChange DetectedA note now states that PubMed automatically populates the Publications section and items may not be about the study, and the revision label was updated from v3.2.0 to v3.3.2.SummaryDifference0.1%

- Check54 days agoChange DetectedA funding-lapse notice previously displayed on the page has been removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check75 days agoChange DetectedThe screenshots show only minor layout adjustments to the Study Details page with no new or removed study information, eligibility criteria, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check96 days agoChange Detected- Added a government operating status notice and a version update to v3.2.0; - Removed the old v3.1.0 revision tag.SummaryDifference3%

- Check104 days agoChange DetectedVersion updated from v3.0.2 to v3.1.0; substantive page content remains unchanged.SummaryDifference0.1%

Stay in the know with updates to Seladelpar in PBC Subjects Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Seladelpar in PBC Subjects Clinical Trial page.